A Monte Carlo framework for managing biological variability in manufacture of autologous cell therapy from mesenchymal stromal cells therapies. (2020)
Attributed to:
Developing Efficient Models to Define Economic and Low Risk High Value Manufacture of Cell Based Products
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jcyt.2020.01.006
PubMed Identifier: 32113873
Publication URI: http://europepmc.org/abstract/MED/32113873
Type: Journal Article/Review
Volume: 22
Parent Publication: Cytotherapy
Issue: 4
ISSN: 1465-3249